1. Repository of Kharkiv National Medical University

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 28 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
Rozhdestvenska A, Babak O, Zhelezniakova N.pdf.jpg2020-11Non-alcoholic fatty liver disease and hypertension: clinical variability of comorbidityРождественська, Анастасія Олександрівна; Железнякова, Наталя Мерабівна; Rozhdestvenska, Anastasiia; Babak, Oleg; Zhelezniakova, Natalia
Rozhdestvenska_Metabolism_0127.pdf.jpg2021-01Non-alcoholic Fatty Liver Disease in Patients with Hypertension: Carbohydrate Metabolism and Liver Parenchyma ConditionRozhdestvenska, Anastasiia; Zhelezniakova, Natalia; Kurinna, Olena
Babak. Prosolenko Markers of liver damage in comorbidity of nonalcoholic liver disease and hypertension2.pdf.jpg2020Markers of liver damage in comorbidity of nonalcoholic liver disease and hypertensionBabak, Oleg; Prosolenko, Kostyantyn
Статья Синайко WoS 2021.pdf.jpg2021Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver diseaseBilovol, O.; Kniazkova, I.; Zemlianitsyna, O.; Dunaieva, I.; Romanova, I.; Kurilo, O.; Sinaiko, V.; Kravchun, N.
ISIC2021_abstractbook-Alesandrova 2.pdf.jpg2021The effectiveness of ademetionine on the stages of liver fibrosis and the pentraxin-3 levels in patients with non-alcoholic fatty liver disease on the background of arterial hypertensionAleksandrova, Tetiana; Malhotra, Shubham; Suman, Tanu
ISIC2021_abstractbook-Alesandrova 1.pdf.jpg2021Clinical significance of pentraxin-3 and C-reactive protein in the differentiation of stages of nonalcoholic fatty liver diseaseAleksandrova, Tetiana; Dhainy, Ali; Isam, Mohamed
Rozhdestvenska_hkccasc2021.pdf.jpg2021-07Hypertension as an intensification factor of metabolic and inflammatory deviations in patients with non-alcoholic fatty liver diseaseZhelezniakova, Natalia; Rozhdestvenska, Anastasiia
Bilovol et al_Hepatic fibrosis as an additional.pdf.jpg2021Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver diseaseBilovol, O.; Kniazkova, I.; Zemlianitsyna, O.; Dunaieva, I.; Romanova, I.; Kurilo, O.; Sinaiko, V.; Kravchun, N.
Dunaieva et al_Adiponektinemia in patients.pdf.jpg2021Adiponektinemia in patients with type 2 diabetes mellitus and var ious stages of non-alcoholic fat liver diseaseDunaieva, I.; Kravchun, N.; Zemlianitsyna, O.
Rozhdestvenska_Article_Maltepe.pdf.jpg2021-08Diagnostic capabilities of kallistatin, IL-10 and IL-1β in patients with non-alcoholic fatty liver disease and hypertensionZhelezniakova, Natalia; Rozhdestvenska, Anastasiia

Discover